|
1
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH: WHO classification of tumours of female reproductive
organs. Fourth Edition. World Health Organization; pp. 132–133.
2014
|
|
2
|
Shen Y, Wang Y, Shi Y, Liu J and Liu Y:
Clinicopathologic study of endometrial dedifferentiated
endometrioid adenocarcinoma: A case report. Int J Clin Exp Pathol.
5:77–82. 2012.PubMed/NCBI
|
|
3
|
Lynch HT and de la Chapelle A: Genetic
susceptibility to non-polyposis colorectal cancer. J Med Genet.
36:801–818. 1999.PubMed/NCBI
|
|
4
|
Kazu U, Kyosuke Y, Mitsuyoshi U, Yoshio I,
Misako S, Takashi N, Hiroyuki T, Aikou O, Misato S, et al:
Association of extracellular matrix metalloproteinase inducer in
endometrial carcinoma with patient outcomes and clinicopathogenesis
using monoclonal antibody 12C3. Oncol Rep. 17:731–735. 2006.
|
|
5
|
Silva EG, Deavers MT, Bodurka DC and
Malpica A: Association of low-grade endometrioid carcinoma of the
uterus and ovary with undifferentiated carcinoma: A new type of
dedifferentiated carcinoma? Int J Gynecol Pathol. 25:52–58. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu ES, Shih Le-M and Díaz-Montes TP:
Dedifferentiated endometrioid adenocarcinoma: An under-recognized
but aggressive tumor? Gynecol Oncol Rep. 5:25–27. 2013. View Article : Google Scholar
|
|
7
|
Hoang LN, Lee YS, Karnezis AN,
Tessier-Cloutier B, Almandani N, Coatham M, Gilks CB, Soslow RA,
Stewart CJ, Köbel M and Lee CH: Immunophenotypic features of
dedifferentiated endometrial carcinoma - insights from
BRG1/INI1-deficient tumours. Histopathology. 69:560–569. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tafe LJ, Garg K, Chew I, Tornos C and
Soslow RA: Endometrial and ovarian carcinomas with undifferentiated
components: Clinically aggressive and frequently underrecognized
neoplasms. Mod Pathol. 23:781–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanis MJ, Rahaman J, Moshier EL,
Zakashansky K, Chuang L and Kolev V: Detection and correlation of
pre-operative, frozen section, and final pathology in high-risk
endometrial cancer. Eur J Gynaecol Oncol. 37:338–341.
2016.PubMed/NCBI
|
|
10
|
Jiheun H, Eun YK, Sung ER, Soo YH and
Ahwon L: Dedifferentiated endometrioid carcinoma of the uterus:
report of four cases and review of literature. World J Surg Oncol.
15:172017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ramalingam P, Masand RP, Euscher ED and
Malpica A: Undifferentiated carcinoma of the endometrium: an
expanded immunohistochemical analysis including PAX-8 and
basal-like carcinoma surrogate markers 35. Int J Gynecol Pathol.
410–418. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garg K, Leitao MM Jr, Kauff ND, Hansen J,
Kosarin K, Shia J and Soslow RA: Selection of endometrial
carcinomas for DNA mismatch repair protein immunohistochemistry
using patient age and tumor morphology enhances detection of
mismatch repair abnormalities. Am J Surg Pathol. 33:925–933. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu KH, Schorge JO, Rodabaugh KJ, Daniels
MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM and
Broaddus RR: Prospective determination of prevalence of lynch
syndrome in young women with endometrial cancer. J Clin Oncol.
25:5158–5164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Berretta R, Patrelli TS, Faioli R, Mautone
D, Gizzo S, Mezzogiorno A, Giordano G and Modena AB:
Dedifferentiated endometrial cancer: An atypical case diagnosed
from cerebellar and adrenal metastasis: Case presentation and
review of literature. Int J Clin Exp Pathol. 6:1652–1657.
2013.PubMed/NCBI
|
